Abstract
Patient compliance with treatment regimens remains a serious problem in the treatment of tuberculosis (TB) patients. In the decades after the advent of anti-TB drugs in the late 1940s, Directly Observed Therapy (DOT) gradually became a widely accepted and recommended staple of TB treatment management, resulting in the evolution of DOT-based systems worldwide that attempt to ensure patient compliance with their treatment schedules. Most of these DOT programs involve selecting and training supervisors to monitor, record, and enforce patient treatment regimens. Although widely used, DOT programs face many challenges today, especially in low-resource areas such as rural China. In response to these problems, current developments in treatment management involve utilizing new technology and research to discover more effective and efficient ways of ensuring that patients take their medication.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Bastian, I., Stapledon, R., & Colebunders, R. (2003). Current thinking on the management of tuberculosis. Current Opinion in Pulmonary Medicine, 9(3), 186–192.
Cai, J., & Chen, X. (2003). The principle in tuberculosis control in China. Beijing: People’s Public Health Publishing House.
Chen, J., Hu, D., Wang, Y., Smith, H., Liu, X., & Wang, T. (2006). Qualitative analysis on the impact factors during the implementation of directly observed medication for smear-positive tuberculosis patients. Modern Preventive Medicine, 11, 2024–2026.
Cheng, X., & Gong, W. (2004). Analysis on the effect of full medication management supplemented by family supervision in rural areas. Strait Journal of Preventive Medicine, 31(3), 3–4.
Claxton, A. J., Cramer, J., & Pierce, C. (2001). A systematic review of the associations between dose regimens and medication compliance. Clinical Therapeutics, 23(8), 1296–1310.
Dai, Y. S., Li, Q., & Duanmu, H. J. (1994). Comparing study on full course management and DOT of PTB patients. Chinese Journal of Tuberculosis and Respiratory Diseases, 17(5), 278–280.
Hu, D., Liu, X., Chen, J., Wang, Y., Wang, T., Zheng, W., et al. (2008). Direct observation and adherence to tuberculosis treatment in Chongqing, China: A descriptive study. Health Policy and Planning, 23(1), 43–55.
Hu, D. Y., Wang, T., Liu, X. Y., Chen, J., Wang, Y., Zheng, W., et al. (2006). Facts on the performance of directly observed medication in smear-positive tuberculosis patients in Chongqing and the impact factors. China Health Resources, 9(5), 219–221.
Khan, M. A., Walley, J. D., Witter, S. N., Imran, A., & Safdar, N. (2002). Costs and cost-effectiveness of different DOT strategies for the treatment of tuberculosis in Pakistan. Health Policy and Planning, 17(2), 178–186.
Li, S. S., Xu, R. X., & Xiao, C. Z. (1965). Preliminary analysis on the chemotherapy of newly diagnosed smear positive patients. Chinese Journal of Antituberculosis, 6(4), 220–223.
Lienhardt, C., & Ogden, J. A. (2004). Tuberculosis control in resource poor countries: Have we reached the limits of the universal paradigm? Tropical Medicine and International Health, 9(7), 833–841.
Menzies, D., Dion, M. J., Francis, D., Parisien, I., Rocher, I., Mannix, S., et al. (2005). In closely monitored patients, adherence in the first month predicts completion of therapy for latent tuberculosis infection. International Journal of Tuberculosis and Lung Disease, 9(12), 1343–1348.
Ministry of Health of The People’s Republic of China. (1992). National TB epidemiological survey in 1990. Beijing: Ministry of Health.
Ministry of Health, Disease Control Division. (2002). China tuberculosis control implementation guide. Beijing: Ministry of Health.
Ministry of Health, Disease Control Division, Ministry of Health Foreign Loan Office, & Chinese Center for Disease Control and Prevention. (2005). Report on the social assessment of the China Tuberculosis Control Project. Beijing: Ministry of Health.
Ministry of Health, Disease Control Division, Ministry of Health, Medical Administration Division, & Chinese Center for Disease Control and Prevention. (2009). Guide for the implementation of tuberculosis control in China. Beijing: China Union University Publishing House.
Moulding, T. S., & Caymittes, M. (2002). Managing medication compliance of tuberculosis patients in Haiti with medication monitors. International Journal of Tuberculosis and Lung Disease, 6(4), 313–319.
Moulding, T. S., Onstad, G. D., & Sbarbaro, J. A. (1970). Supervision of outpatient drug therapy with the medication monitor. Annals of Internal Medicine, 73(4), 559–564.
Paramasivan, R., Parthasarathy, R. T., & Rajasekaran, S. (1993). Short course chemotherapy: A controlled study of indirect defaulter retrieval method. Indian Journal of Tuberculosis, 40, 185–190.
Rusen, I. D., Aït-Khaled, N., Alarcón, E., Billo, N., Bissell, K., Boillot, F., et al. (2007). Cochrane systematic review of directly observed therapy for treating tuberculosis: Good analysis of the wrong outcome. International Journal of Tuberculosis and Lung Disease., 11(2), 120–121.
Sonnenberg, P., Ross, M. H., Shearer, S. C., & Murray, J. (1998). The effect of dosage cards on compliance with directly observed therapy in hospital. International Journal of Tuberculosis and Lung Disease, 2(2), 168–171.
Sun, Q., Meng, Q., Yip, W., Yin, X., & Li, H. (2008). DOT in rural China: Experience from a case study in Shandong Province, China. International Journal of Tuberculosis and Lung Disease, 12(6), 625–630.
Tu, D., Wan, L., & Wang, L. (2013). The theory and practice of modern tuberculosis control. Beijing: Military Medical Science Publishing House.
Tuberculosis Coalition for Technical Assistance. (2006). International Standards for Tuberculosis Care (ISTC). The Hague: Tuberculosis Coalition for Technical Assistance.
Volmink, J., & Garner, P. (2007). Directly observed therapy for treating tuberculosis. Cochrane Database of Systematic Reviews, (4), CD003343.
Volmink, J., Matchaba, P., & Garner, P. (2000). Directly observed therapy and treatment adherence. Lancet, 355(9212), 1345–1350.
Wang, L., Liu, J., & Jiang, W. (2004). Prevention and treatment of tuberculosis. Beijing: China Union University Publishing House.
WHO. (2006). The Stop TB Strategy. Geneva: World Health Organization.
WHO. (2008). Global tuberculosis control: Surveillance, planning, financing. Geneva: World Health Organization.
Xiao, D., & Wang, Y. (2008). The mid-term evaluation report on the National Tuberculosis Control Program (2001-2010). Beijing: China Union University Publishing House.
Yan, B., & Duanmu, H. (2003). Tuberculosis. Beijing: Beijing Press.
Zhang, L. (1997). Best practices for tuberculosis control: Short-course chemotherapy under supervision by medical staff directly. China Public Health, 13(12), 709–710.
Zhang, B., & Wang, L. (2010). Epoch-making initiative: World Bank Loan/United Kingdom granted tuberculosis project in China: Progress and achievement. Beijing: China Social Publishing House.
Zhang, L. X., Wu, Q. C., Lv, S. M., Liu, C. W., & Sun, F. X. (1980). Preliminary analysis on non-hospitalized TB patient DOT in rural area. The Journal of the Chinese Antituberculosis Association, 1, 13–17.
Zheng, Y., Wang, J., Zhou, Y., et al. (2009). The survey and analysis of treatment adherence for the smear positive pulmonary tuberculosis patients in Jiangsu province. The Bulletin of Nanjing Medical University, 29(10), 1384.
Zhong, Q., & Tang, D. (2013). The minute book of anti-tuberculosis in new China. Guangzhou: Guangdong People’s Publishing House.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer Science+Business Media LLC
About this chapter
Cite this chapter
Jiang, S., Hu, D., Liu, X. (2017). DOT Status and Development in China. In: Lu, Y., Wang, L., Duanmu, H., Chanyasulkit, C., Strong, A., Zhang, H. (eds) Handbook of Global Tuberculosis Control. Springer, Boston, MA. https://doi.org/10.1007/978-1-4939-6667-7_9
Download citation
DOI: https://doi.org/10.1007/978-1-4939-6667-7_9
Published:
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4939-6665-3
Online ISBN: 978-1-4939-6667-7
eBook Packages: MedicineMedicine (R0)